FDA Inspection
Hisamitsu Pharmaceutical Co., Inc.Hisamitsu Pharmaceutical Co., Inc. – FDA Inspection, Jul 4, 2025
Record Details
This FDA Inspection record concerns Hisamitsu Pharmaceutical Co., Inc., with an inspection on July 4, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 640ccb07-e937-45de-be0d-2bb9effb19ba
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1273761
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hisamitsu Pharmaceutical Co., Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 31, 2019 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| September 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 17, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 1, 2009 | NAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Other documents for Hisamitsu Pharmaceutical Co., Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.